|
|
|
|||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
TB-Related ArticlesReturn to TB-Related Articles Table of Contents Journal Articles Published by Division of TB Elimination (DTBE) Authors January - December 2003 Lobato MN, Mohle-Boetani JC, Royce SE. Yield of source-case and contact investigations in identifying previously undiagnosed tuberculosis. Int J Tuberc Lung Dis 2003; 7(Suppl. 3): 5391-5396. Adatu F, Odeke R, Mugenyi M, Gargioni G, McCray E, Schneider E, and Maher D. Implementation of the DOTS strategy for tuberculosis control in rural Kiboga District, Uganda, offering patients the option of treatment supervision in the community, 1998-1999. Int J Tuberc Lung Dis 2003 Sep; 7(9, Suppl 1): S63-S71. Burman W, Breese P, Weis S, Bock N, Bernardo J, Vernon A and the TB Trials Consortium. The effects of local review on informed consent documents from a multicenter clinical trials consortium. Controlled Clinical Trials 2003 (June); 24(3): 245-255. Frieden T R, Sterling T R, Munsiff S S, Watt C J, and Dye C. Tuberculosis. Lancet 2003 Sep 13; 362 (9387): 887-899. Frieden TR and Driver CR. Tuberculosis control: past 10 years and future progress. Tuberculosis 2003: 83(1-3): 82-85. Frieden TR and Khatri GR. Impact of national consultants on successful expansion of effective tuberculosis control in India. Int J Tuberc Lung Dis 2003 Sep; 7(9): 837-841. Garber E, San Gabriel P, Lambert L, and Saiman L. A survey of latent tuberculosis infection among laboratory healthcare workers in New York City. Infection Control and Hospital Epidemiology 2003 Nov; 24(11): 801-6. Kherosheva T, Thorpe L E, Kiryanova E, Rybka L, Gerasichev V, Shulgina M, Nemtsova E, Aptekar T, Kluge H, Jakubowiak W, Grzemska M, Aquino G, Wells C, and Kazionny B. Encouraging outcomes in the first year of a TB control demonstration program: Orel Oblast, Russia. Int J Tuberc Lung Dis 2003 Nov; 7(11): 1045-1051. Kim D Y, Ridzon R, Giles B, Mireles T, Garrity K, Hathcock A L, Crowder D, Jackson R, and Taylor Z. A no-name tuberculosis tracking system. Am J Public Health 2003 Oct; 93(10): 1637-1639. Koppaka VR, Harvey E, Mertz B, Johnson BA. Risk factors associated with tuberculin skin test positivity among university students and the use of such factors in the development of a targeted screening program. Clin Infect Dis 2003 Mar 1; 36(5): 599-607. Larson J L, Lambert L, Stricof R L, Driscoll J, McGarry M A, and Ridzon R. Potential nosocomial exposure to Mycobacterium tuberculosis from a bronchoscope. Infection Control and Hospital Epidemiology 2003 Nov; 24(11): 825-30. Li JH, Driver CR, Munsiff SS, Yip R, and Fujiwara PI. Differential decline in tuberculosis incidence among US- and non-US-born persons in New York City. Int J Tuberc Lung Dis 2003 May; 7(5): 451-457. Lobato MN, Leary L, Simone P. Treatment of latent TB in correctional facilities, a challenge for TB elimination. Am J Prev Med 2003; 24(3): 249-253. LoBue P A and Moser K S. Use of isoniazid for latent tuberculosis infection in a public health clinic. Am J Respir Crit Care Med 2003 Aug 15; 168(4): 443-447. LoBue PA, Betacourt W, Peter C, Moser KS. Epidemiology of Mycobacterium bovis disease in San Diego County, 1994-2000. Int J Tuberc Lung Dis 2003 Feb; 7(2): 180-5. Lockman S, Hone N, Kenyon TA, et al. Etiology of pulmonary infections in predominantly HIV-infected adults with suspected tuberculosis, Botswana. Int J Tuberc Lung Dis 2003 Aug; 7(8): 714-723. Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Iademarco MF. Detection of Mycobacterium tuberculosis infection by whole-blood interferon-release assay. Clin + Dis 2003:36; 1207-1208. Letter to editor. McElroy PD, Southwick KL, Fortenberry ER, Levine EC, Diem LA, Woodley CL, Williams PM, McCarthy KD, Ridzon R, Leone PA. Outbreak of tuberculosis among homeless persons coinfected with human immunodeficiency virus. Clin Infect Dis 2003; 36: 1305-12. McLaughlin SI, Spradling P, Drociuk D, Ridzon R, Pozsik CJ, and Onorato I. Extensive transmission of Mycobacterium tuberculosis among congregated, HIV-infected prison inmates in South Carolina, United States. Int J Tuberc Lung Dis 2003 Jul; 7(7): 665-672. Moalosi G, Floyd K, Phatshwane J, Moeti T, Binkin N, and Kenyon T. Cost-effectiveness of home-based care versus hospital care for chronically ill tuberculosis patients, Francistown, Botswana. Int J Tuberc Lung Dis 2003 Sep; 7(9, Suppl 1): S80-S85. Morozova I, Riekstina V, Sture G, Wells C, and Leimane V. Impact of the growing HIV-1 epidemic on multidrug-resistant tuberculosis control in Latvia. Int J Tuberc Lung Dis 2003 Sep; 7(9): 903-906. Mosimaneotsile B, Talbot E A, Moeti T L, Hone N M, Moalosi G, Moffat H J, Lee E J, and Kenyon T A. Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana. Lancet 2003 Nov 8; 362 (9395): 1551-2. Munsiff SS, Nivin B, Sacajiu G, Mathema B, Bifani P, and Kreiswirth BN. Persistence of a highly resistant strain of tuberculosis in New York City during 1990-1999. J Infect Dis 2003 Aug 1; 188 (3): 356-63. Nuermberger EL, Yoshimatsu T, Tyagi S, O'Brien RJ, Vernon AN, Chaisson RE, Bishai WR, Grosset JH. Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis. Am J Respir Crit Care Med 2003 Oct 24 [Epub ahead of print]. O'Brien RJ. Development of fluoroquinolones as first-line drugs for tuberculosis--at long last! Am J Respir Crit Care Med 2003 Dec 1;168(11):1266-8. Radhakrishna S, Frieden T R, and Subramani R. Association of initial tuberculin sensitivity, age, and sex with the incidence of tuberculosis in South India: a 15-year follow-up. Int J Tuberc Lung Dis 2003 Nov; 7(11): 1083-1091. Reichard AA, Lobato MN, Roberts CA, Bazerman LB, Hammett TM. Assessment of tuberculosis screening and management practices of large jail systems. Public Health Rep 2003 Nov-Dec;118(6): 500-507. Schneider E and Castro KG. Tuberculosis trends in the United States, 1992-2001. Tuberculosis 2003; 83(1-3): 21-29. Selvakumar N, Govindan D, Chandu NA, Frieden TR, Narayanan PR. Processing sputum specimens in a refrigerated centrifuge does not increase the rate of isolation of Mycobacterium tuberculosis. J Clin Microbiol 2003 Jan; 41(1): 469-71. Sterling TR, Lehmann HP, Frieden TR. Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis. BMJ 2003 Mar 15; 326: 574-79. Talbot EA, Hone NM, Moffat HJ, et al. The validity of HIV testing using sputum from suspected tuberculosis patients, Botswana, 2001. Int J Tuberc Lung Dis 2003 Aug; 7(8): 710-713. Talbot EA, Kenyon TA, Mwasekaga MJ, Moeti TL, Mallon V, and Binkin NJ. Control of anti-tuberculosis drug resistance in Botswana. Int J Tuberc Lung Dis 2003 Jan; 7(1): 72-77. Uthaivoravit W, Yanai H, Tappero JW, et al. Impact of enhanced notification of tuberculosis laboratory results to minimise treatment delay, Chiang Rai Hospital, Northern Thailand. Int J Tuberc Lung Dis 2003 Jan; 7(1): 46-51. Weiner M, Burman W, Vernon A, et al. Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine. Am J Respir Crit Care Med 2003 May 15; 167(10): 1341-1347. White MC, Gournis E, Kawamura M, Menendez E, and Tulsky JP. Effect of directly observed preventive therapy for latent tuberculosis infection in San Francisco. Int J Tuberc Lung Dis 2003 Jan; 7(1): 30-35.
Last Reviewed: 05/18/2008 |
|
|
If you would like to order any of the DTBE publications please visit the online order form. You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format. Download the Adobe Acrobat™ Reader. If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available. Division of Tuberculosis Elimination
Centers for Disease Control & Prevention |